Better health information helps better decision-making, for both patients and healthcare providers
Are you suffering from diseases that have yet to manifest symptoms?
The potential benefits of accurate diagnostics are immense, but target molecules that indicate the presence of disease often exist in quantities too low to be detected in collected samples.
PHASE’s proprietary technology, PHASIFY, is an innovative solution to the problem of low-concentration target molecule detection.
By improving sample quality, PHASIFY increases the sensitivity, performance and affordability of point-of-care and lab-based tests
The beauty of the PHASIFY technology lies in its simplicity.
Imagine if you can concentrate an entire glass of salt water inside just the volume of a single drop, the taste of salt that was hard to detect in the full glass all of a sudden becomes incredibly apparent.
PHASIFY works the same way, by concentrating scant biological clues spread across the sample in an accelerated and seamless manner, the targeted molecules become much faster and easier to detect.
